179 related articles for article (PubMed ID: 28784966)
1. A Human Glioblastoma Organotypic Slice Culture Model for Study of Tumor Cell Migration and Patient-specific Effects of Anti-Invasive Drugs.
Parker JJ; Lizarraga M; Waziri A; Foshay KM
J Vis Exp; 2017 Jul; (125):. PubMed ID: 28784966
[TBL] [Abstract][Full Text] [Related]
2. Gefitinib selectively inhibits tumor cell migration in EGFR-amplified human glioblastoma.
Parker JJ; Dionne KR; Massarwa R; Klaassen M; Foreman NK; Niswander L; Canoll P; Kleinschmidt-Demasters BK; Waziri A
Neuro Oncol; 2013 Aug; 15(8):1048-57. PubMed ID: 23749785
[TBL] [Abstract][Full Text] [Related]
3. Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain.
Ravin R; Suarez-Meade P; Busse B; Blank PS; Vivas-Buitrago T; Norton ES; Graepel S; Chaichana KL; Bezrukov L; Guerrero-Cazares H; Zimmerberg J; Quiñones-Hinojosa A
J Neurooncol; 2023 Aug; 164(1):43-54. PubMed ID: 37490233
[TBL] [Abstract][Full Text] [Related]
4. Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.
Jensen SS; Petterson SA; Halle B; Aaberg-Jessen C; Kristensen BW
BMC Cancer; 2017 Mar; 17(1):178. PubMed ID: 28270132
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral heterogeneity of endogenous tumor cell invasive behavior in human glioblastoma.
Parker JJ; Canoll P; Niswander L; Kleinschmidt-DeMasters BK; Foshay K; Waziri A
Sci Rep; 2018 Dec; 8(1):18002. PubMed ID: 30573757
[TBL] [Abstract][Full Text] [Related]
6. An advanced glioma cell invasion assay based on organotypic brain slice cultures.
Eisemann T; Costa B; Strelau J; Mittelbronn M; Angel P; Peterziel H
BMC Cancer; 2018 Jan; 18(1):103. PubMed ID: 29378533
[TBL] [Abstract][Full Text] [Related]
7. Impact of mesenchymal stem cells' secretome on glioblastoma pathophysiology.
Vieira de Castro J; Gomes ED; Granja S; Anjo SI; Baltazar F; Manadas B; Salgado AJ; Costa BM
J Transl Med; 2017 Oct; 15(1):200. PubMed ID: 28969635
[TBL] [Abstract][Full Text] [Related]
8. Time-lapse phenotyping of invasive glioma cells ex vivo reveals subtype-specific movement patterns guided by tumor core signaling.
Fayzullin A; Tuvnes FA; Skjellegrind HK; Behnan J; Mughal AA; Langmoen IA; Vik-Mo EO
Exp Cell Res; 2016 Dec; 349(2):199-213. PubMed ID: 27515001
[TBL] [Abstract][Full Text] [Related]
9. Antitumor compound testing in glioblastoma organotypic brain cultures.
Biggs T; Foreman J; Sundstrom L; Regenass U; Lehembre F
J Biomol Screen; 2011 Sep; 16(8):805-17. PubMed ID: 21807962
[TBL] [Abstract][Full Text] [Related]
10. Small-molecule agonists of mammalian Diaphanous-related (mDia) formins reveal an effective glioblastoma anti-invasion strategy.
Arden JD; Lavik KI; Rubinic KA; Chiaia N; Khuder SA; Howard MJ; Nestor-Kalinoski AL; Alberts AS; Eisenmann KM
Mol Biol Cell; 2015 Nov; 26(21):3704-18. PubMed ID: 26354425
[TBL] [Abstract][Full Text] [Related]
11. Naringenin inhibited migration and invasion of glioblastoma cells through multiple mechanisms.
Chen YY; Chang YM; Wang KY; Chen PN; Hseu YC; Chen KM; Yeh KT; Chen CJ; Hsu LS
Environ Toxicol; 2019 Mar; 34(3):233-239. PubMed ID: 30431227
[TBL] [Abstract][Full Text] [Related]
12. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an advanced
Decotret LR; Shi R; Thomas KN; Hsu M; Pallen CJ; Bennewith KL
Front Oncol; 2023; 13():976945. PubMed ID: 36793608
[TBL] [Abstract][Full Text] [Related]
14. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
Daher A; de Groot J
Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
[TBL] [Abstract][Full Text] [Related]
15. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines.
Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q
Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244
[TBL] [Abstract][Full Text] [Related]
16. Brain-Mimetic 3D Culture Platforms Allow Investigation of Cooperative Effects of Extracellular Matrix Features on Therapeutic Resistance in Glioblastoma.
Xiao W; Zhang R; Sohrabi A; Ehsanipour A; Sun S; Liang J; Walthers CM; Ta L; Nathanson DA; Seidlits SK
Cancer Res; 2018 Mar; 78(5):1358-1370. PubMed ID: 29282221
[TBL] [Abstract][Full Text] [Related]
17. CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma.
Avril T; Etcheverry A; Pineau R; Obacz J; Jegou G; Jouan F; Le Reste PJ; Hatami M; Colen RR; Carlson BL; Decker PA; Sarkaria JN; Vauléon E; Chiforeanu DC; Clavreul A; Mosser J; Chevet E; Quillien V
Clin Cancer Res; 2017 Dec; 23(23):7360-7374. PubMed ID: 28939749
[No Abstract] [Full Text] [Related]
18. Swelling-induced chloride current in glioblastoma proliferation, migration, and invasion.
Wong R; Chen W; Zhong X; Rutka JT; Feng ZP; Sun HS
J Cell Physiol; 2018 Jan; 233(1):363-370. PubMed ID: 28262948
[TBL] [Abstract][Full Text] [Related]
19. Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines.
Jung TY; Jung S; Ryu HH; Jeong YI; Jin YH; Jin SG; Kim IY; Kang SS; Kim HS
J Neurosurg; 2008 Aug; 109(2):273-84. PubMed ID: 18671640
[TBL] [Abstract][Full Text] [Related]
20. Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.
Tivnan A; Heilinger T; Ramsey JM; O'Connor G; Pokorny JL; Sarkaria JN; Stringer BW; Day BW; Boyd AW; Kim EL; Lode HN; Cryan SA; Prehn JH
Oncotarget; 2017 Mar; 8(10):16605-16620. PubMed ID: 28178667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]